Publication | Open Access

Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis model

Medicinal ChemistryVivo Psoriasis ModelMedicineSelective Tyk2 InhibitorsPharmacologyImidazopyridine ScaffoldClinical DermatologyPharmacotherapyDermatologyExperimental DermatologyPsoriatic ArthritisPharmaceutical ChemistryDrug Discovery